May 4, 2022

Featuring a slide presentation and related discussion from Dr David O'Malley, including the following topics:

• Updates on ovarian cancer from the 2022 SGO Annual Meeting on Women’s Cancer (0:00)
• Updates from clinical trials evaluating PARP inhibitors alone or in combination as neoadjuvant, adjuvant and maintenance therapy (7:25)
• Emerging data and ongoing clinical trials with novel agents: SORAYA, MIRASOL, PICCOLO, UpRi, UPLIFT, UPGRADE and UP-NEXT (16:10)

CME information and select publications